Clinical Trials on PSA Progression in France

Total 210 results

Assistance Publique Hopitaux De Marseille

Completed

A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours. (SFCE METRO 01)

Survival Without Progression

France
University Hospital, Lille

Recruiting

Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease (KETAPAL)

Depression

France
Assistance Publique Hopitaux De Marseille

Completed

Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy (RIVA-PSP)

Progressive Supranuclear Palsy (PSP)

France
Central Hospital, Nancy, France

Completed

Effect of Orthokeratology on Myopia Progression in French Children

Myopia Progression

France
Centre Leon Berard
National Cancer Institute, France; Fondation ARC

Completed

Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive (PIK-ORL)

Head and Neck Neoplasms | Neoplasm Metastasis | Progressive Disease | Recurrent Disease

France
Hospices Civils de Lyon

Recruiting

Management of Progressive Disease in Idiopathic Pulmonary Fibrosis (PROGRESSION)

Progressive Idiopathic Pulmonary Fibrosis

France
UNICANCER

Completed

Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab

Colorectal Cancer

France
Hospital St. Joseph, Marseille, France

Recruiting

Validation of Ultrasound "Angle of Progression" Measurement to Decrease the Cesarean Rate (DELIVERY)

Prolonged Second Stage of Labor

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Descriptive Observational Study of Patient-performed Pre-oxygenation (ApréOx)

Anxiety | Anesthesia | ASA Physical Status I | ASA Physical Status II

France
European Georges Pompidou Hospital
APHP

Recruiting

Pronostic and Predictive Value of EMT in Localized Lung Cancer (TWISTlung)

Progression | Surgery | NSCLC, Stage I, II, IIIA, IIIB | Epithelial Mesenchymal Transition

France
Poitiers University Hospital

Recruiting

New Imaging Biomarkers Predictive of MA Progression (MR7T-PRADA)

Alzheimer Disease | Magnetic Resonance Spectroscopy | Ultra High Field 7T | Progression of Disease | MR Biomarkers

France
University Hospital, Montpellier

Recruiting

Vitreous Detachment and Glaucoma Progression (REVEAL)

Glaucoma | Posterior Vitreous Detachment

France
Centre Hospitalier Universitaire, Amiens

Completed

Neuropsychological Indicators of SCD Progression (SCD-CI)

Neurocognitive Disorders | Neurodegenerative Diseases | Biomarkers | Cognitive Decline | Subjective Cognitive Decline | Cognitive Assessment

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Tumor Rebiopsy During Progression Under Immunotherapy for Patients With Lung Cancer (REBIMMUNE)

Lung Cancer

France
University Hospital, Rouen

Active, not recruiting

Aortic Stenosis: Determinants of Progression, Severity and Left Ventricular Remodeling (AS-PROGRESSION)

Aortic Valve Stenosis

France
Assistance Publique - Hôpitaux de Paris

Completed

FFOCT for the Diagnosis of Prostate Cancer (BIOMAGIC01)

Patients With PSA Level 4.0 ng/mL

France
Assistance Publique - Hôpitaux de Paris

Unknown

Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma (KAPKEY)

Kaposi Sarcoma | Progression, Disease

France
University Hospital, Strasbourg, France

Active, not recruiting

Topical 0.01% Atropine for the Control of Fast Progressing Myopia (Myopie-STOP)

Childhood | Myopia Progressing

France
University Hospital, Montpellier

Completed

Wean Obese Study : Determination of the Optimal Spontaneous Breathing Trial for Obese Patient

Obesity | Respiratory Failure | PSV 7cmH2O PEEP 7cmH2O | PSV 7 cmH2O PEEP 0 cmH20 | CPAP 7 cmH2O | PSV 0 cmH20 PEEP 0 cmH2O | T-Tube | Post-extubation in Spontaneous Breathing and/or in NIV

France
Rennes University Hospital

Recruiting

Motor Asymmetry in Progressive Multiple Sclerosis Patients (MAP-MS)

Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive

France
Assistance Publique - Hôpitaux de Paris

Completed

Imaging of Intracerebral Inflammation in MS (INFLASEP)

Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive

France
UNICANCER
Seagen Inc.; ARCAGY/ GINECO GROUP

Recruiting

Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer (InTTercePT)

Metastatic Breast Cancer With a Isolated Brain Progression

France
University Hospital, Montpellier

Completed

Disparity Between Ultrasound- and Clinical Findings in Psoriatic Arthritis in Remission (PARURE)

PsA Patients Fulfilling CASPAR Criteria in Remission

France
Soutien aux Actions contre les Maladies du Globule...
Novartis

Completed

"Association of Proteinuria and Progression of Kidney Dysfunction in Sickle Cell Disease"Disease (CSEG101A0FR01)

Change in Albumin to Creatinine Ratio and Glomerular Filtration Rate | Progression of Kidney Failure and or All-cause Mortality

France
University Hospital, Toulouse
Centre de Référence National du Kératocône; Sooft Italia

Terminated

Non-inferiority Trial of Iontophoretic Corneal Collagen Crosslinking (CXL) Compared to Standard Corneal Collagen Crosslinking in Progressive Keratoconus. (IONTO-CXL)

Progressive Keratoconus

France
Assistance Publique - Hôpitaux de Paris
Company EUROS

Completed

Surgical Treatment of Progressive Scoliosis With "NEMOST" Growing Rod (NEMOST)

Progressive Scoliosis

France
Hôpital Cochin
Assistance Publique - Hôpitaux de Paris

Completed

Energy for Lymphocytes (ELY)

Non-small Cell Lung Cancer | Progression, Disease

France
Assistance Publique - Hôpitaux de Paris

Unknown

Characterisation of Primary Progressives Aphasias (CAPP)

Aphasia Primary Progressive

France
Rheumazentrum Ruhrgebiet
PPD; Centocor BV; Trial Coordination Center, 9713 GZ Groningen

Unknown

Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

Belgium, Germany, Finland, France, Netherlands, United Kingdom
Nantes University Hospital

Completed

Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis (BIOSEP)

Progressive Multiple Sclerosis

France
AlzProtect SAS

Active, not recruiting

A Study to Assess Tolerability, Safety, Pharmacokinetics and Effect of AZP2006 in Patients With PSP

Progressive Supranuclear Palsy

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Nivolumab for Pediatric and Adult Relapsing/Refractory ALK+, for Evaluation of Response in Patients With Progressive Disease (Cohort 1) or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse (Cohort 2) (NIVO-ALCL)

Relapsing/Refractory ALK+ Anaplastic Large Cell Lymphoma

France, Denmark, Netherlands
University Hospital, Montpellier

Completed

Use of Exhaled Carbon Dioxyde for Monitoring the Native Cardiac Function During Mechanical Circulatory Support With Venoarterial By-pass in Intensive Care Unit (CAPNOECMO)

Residual Cardiac Output During PVA-ECMO

France
Latin American Cooperative Oncology Group
GlaxoSmithKline

Completed

Safety Study in Subjects With Metastatic Breast Cancer Who Progressed After Taxanes Treatment. (GLICO-0801)

BRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After Taxanes

Argentina, Brazil, Peru
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET (ReLUTH)

Progressive Disease | Neuroendocrine Tumors | Intestinal Well Differentiated Endocrine Tumor

France
Assistance Publique - Hôpitaux de Paris

Unknown

LIVER FIBROSIS PREVALENCE IN FRANCE (FIBROFRANCE)

Liver Fibrosis Progression in Chronic Liver Disease

France
Assistance Publique - Hôpitaux de Paris

Recruiting

IBD Disease Course of Infliximab-naïve IBD Patients Treated With Subcutaneous Infliximab CT-P13 Remsima® (PRIME)

Inflammatory Bowel Diseases

France
University of California, Irvine

Withdrawn

Gas Kinetics and Metabolism in Anesthesia During Non Steady State

Anesthetized Healthy Patients (ASA 1 or 2) in the Supine Position, Excluding Head, Neck and Head Surgeries | Anesthetized Patient With Severe Systemic Disease (ASA 3 or 4)

United States
Centre Hospitalier Universitaire de Nice

Completed

Automated EDSS Score Calculation by Smartphone Application (Easy EDSS)

MS CHRONIC PROGRESSIVE

France
University Hospital, Montpellier
Genzyme, a Sanofi Company

Terminated

Study by Magnetic Resonance Imaging in the Progressive Forms of Multiple Sclerosis (VASOSEP)

Progressive Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting

France
Amoneta Diagnostics SAS
Assistance Publique - Hôpitaux de Paris; University Hospital, Geneva; University... and other collaborators

Unknown

ADDIA Proof-of-Performance Clinical Study (ADDIA)

Frontotemporal Lobar Degeneration | Progressive Supranuclear Palsy (PSP) | Dementia With Lewy Bodies (DLB) | Corticobasal Degeneration (CBD) | Alzheimer Disease (AD) | Parkinson Disease Dementia (PDD)

Belgium, France, Italy, Switzerland, Turkey
Assistance Publique - Hôpitaux de Paris
Roche Pharma AG; Institut du Cerveau et de la Moelle épinière

Recruiting

Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714 (INN-MS)

Multiple Sclerosis | Relapse | Primary Progressive Multiple Sclerosis

France
Centre Hospitalier Universitaire de Pointe-a-Pitre
Institut National de la Santé Et de la Recherche Médicale, France

Recruiting

Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression. (KP-CARAIBES)

Adenocarcinoma | Neoplasm Metastasis | Prostatic Neoplasm | Neoplasm Recurrence

France, Guadeloupe
Hospices Civils de Lyon

Not yet recruiting

Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete Response Prediction for Localized Breast Cancer Treated by Neoadjuvant Chemotherapy (CERePred)

Breast Cancer

France
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Subcutaneous Apomorphine in the Treatment of Progressive Supranuclear Palsy and Cortico Basal Degeneration (APOPARKA) (APOPARKA)

Corticobasal Degeneration | Progressive Supranuclear Palsy

France
University Hospital, Clermont-Ferrand
MedDay Pharmaceuticals SA; OFSEP (Observatoire Français de la Sclérose en Plaques) and other collaborators

Unknown

Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis (IPBio-SeP)

Progressive Multiple Sclerosis

France
University Hospital, Montpellier

Completed

Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis (AMIS)

Progressive Multiple Sclerosis | Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Controls

France
Groupe Hospitalier Pitie-Salpetriere
Institut National de la Santé Et de la Recherche Médicale, France

Unknown

Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy

Supranuclear Palsy, Progressive

France
University Hospital, Bordeaux
Roche Pharma AG

Recruiting

Cognition Evolution and MRI Markers in PPMS Patients on 2 Years (PRO-COG)

Multiple Sclerosis, Primary Progressive

France
Clementia Pharmaceuticals Inc.

Completed

An Open-Label Extension Study of Palovarotene to Prevent Heterotopic Ossification in People With Fibrodysplasia Ossificans Progressiva (FOP) in France

Fibrodysplasia Ossificans Progressiva

France

Clinical Trials on PSA Progression in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations